Publications
- InnovationMap Houston
Houston biotech company gets green light from FDA to test coronavirus-fighting drug - Press Release
Pulmotect receives FDA approval to commence two Phase-2 trials targeting COVID-19 - Clinical Trials.gov https://www.clinicaltrials.gov/ct2/show/NCT04312997
- Houston Chronicle
Houston researchers test lung inhalant that could protect healthcare workers from COVID-19 - Houston Business Journal
Houston biotech co.’s coronavirus treatment candidate to undergo clinical trials